Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProCeller was a Swedish biotechnology company that specialized in the development of automated cell culture systems for the life science and pharmaceutical industries. The company's flagship product, the ProCeller system, was a closed, automated platform designed for the large-scale expansion of adherent cells, particularly for use in cell therapy manufacturing. By providing a controlled environment that minimized manual handling and contamination risks, the system aimed to standardize cell production and improve the scalability of regenerative medicine. ProCeller was a spin-off from the Karolinska Institute and was acquired by GE Healthcare in 2006 to strengthen its cell therapy and bioprocessing portfolio. The technology was subsequently integrated into GE Healthcare Life Sciences, which is now part of Cytiva.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProCeller System.